A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: Case study

Man Zhao, Jinyan Jiang, Rongrong Zheng, Henna Pearl, Douglas Dickinson, Baiping Fu, Stephen Hsu

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The effects of a proprietary topical formulation containing EGCG-stearate in 100% glycerin USP were studied in two volunteer patients with recurrent herpes simplex (HSV) type 1. Application during early onset (prodromal stage) in a patient with herpes labialis prevented lesion progression. In a second patient with herpetic stomatitis, application of the formula during a later stage (inflammation stage) led to a remarkably shortened duration of symptoms. In contrast, a third patient provided 100% glycerin USP only as placebo failed to demonstrate any therapeutic or preventive effect against lesion occurrence or duration of lesion and healing time. These results suggest that this proprietary topical preparation could be used effectively to prevent and treat HSV-induced symptoms, and warrants further clinical investigation.

Original languageEnglish (US)
Pages (from-to)364-368
Number of pages5
JournalInflammation and Allergy - Drug Targets
Volume11
Issue number5
DOIs
StatePublished - Oct 26 2012

Fingerprint

Stearates
Simplexvirus
Glycerol
Herpetic Stomatitis
Herpes Labialis
Prodromal Symptoms
Herpes Simplex
Human Herpesvirus 1
Volunteers
Placebos
Inflammation
Therapeutics

Keywords

  • Cold sore
  • Green tea polyphenol
  • Herpes labialis
  • Herpes simplex virus
  • Herpes stomatitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus : Case study. / Zhao, Man; Jiang, Jinyan; Zheng, Rongrong; Pearl, Henna; Dickinson, Douglas; Fu, Baiping; Hsu, Stephen.

In: Inflammation and Allergy - Drug Targets, Vol. 11, No. 5, 26.10.2012, p. 364-368.

Research output: Contribution to journalArticle

Zhao, Man ; Jiang, Jinyan ; Zheng, Rongrong ; Pearl, Henna ; Dickinson, Douglas ; Fu, Baiping ; Hsu, Stephen. / A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus : Case study. In: Inflammation and Allergy - Drug Targets. 2012 ; Vol. 11, No. 5. pp. 364-368.
@article{29f5a34eb606497eb591b0684b43728a,
title = "A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus: Case study",
abstract = "The effects of a proprietary topical formulation containing EGCG-stearate in 100{\%} glycerin USP were studied in two volunteer patients with recurrent herpes simplex (HSV) type 1. Application during early onset (prodromal stage) in a patient with herpes labialis prevented lesion progression. In a second patient with herpetic stomatitis, application of the formula during a later stage (inflammation stage) led to a remarkably shortened duration of symptoms. In contrast, a third patient provided 100{\%} glycerin USP only as placebo failed to demonstrate any therapeutic or preventive effect against lesion occurrence or duration of lesion and healing time. These results suggest that this proprietary topical preparation could be used effectively to prevent and treat HSV-induced symptoms, and warrants further clinical investigation.",
keywords = "Cold sore, Green tea polyphenol, Herpes labialis, Herpes simplex virus, Herpes stomatitis",
author = "Man Zhao and Jinyan Jiang and Rongrong Zheng and Henna Pearl and Douglas Dickinson and Baiping Fu and Stephen Hsu",
year = "2012",
month = "10",
day = "26",
doi = "10.2174/187152812803251033",
language = "English (US)",
volume = "11",
pages = "364--368",
journal = "Current Drug Targets: Inflammation and Allergy",
issn = "1871-5281",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - A proprietary topical preparation containing EGCG-stearate and glycerin with inhibitory effects on herpes simplex virus

T2 - Case study

AU - Zhao, Man

AU - Jiang, Jinyan

AU - Zheng, Rongrong

AU - Pearl, Henna

AU - Dickinson, Douglas

AU - Fu, Baiping

AU - Hsu, Stephen

PY - 2012/10/26

Y1 - 2012/10/26

N2 - The effects of a proprietary topical formulation containing EGCG-stearate in 100% glycerin USP were studied in two volunteer patients with recurrent herpes simplex (HSV) type 1. Application during early onset (prodromal stage) in a patient with herpes labialis prevented lesion progression. In a second patient with herpetic stomatitis, application of the formula during a later stage (inflammation stage) led to a remarkably shortened duration of symptoms. In contrast, a third patient provided 100% glycerin USP only as placebo failed to demonstrate any therapeutic or preventive effect against lesion occurrence or duration of lesion and healing time. These results suggest that this proprietary topical preparation could be used effectively to prevent and treat HSV-induced symptoms, and warrants further clinical investigation.

AB - The effects of a proprietary topical formulation containing EGCG-stearate in 100% glycerin USP were studied in two volunteer patients with recurrent herpes simplex (HSV) type 1. Application during early onset (prodromal stage) in a patient with herpes labialis prevented lesion progression. In a second patient with herpetic stomatitis, application of the formula during a later stage (inflammation stage) led to a remarkably shortened duration of symptoms. In contrast, a third patient provided 100% glycerin USP only as placebo failed to demonstrate any therapeutic or preventive effect against lesion occurrence or duration of lesion and healing time. These results suggest that this proprietary topical preparation could be used effectively to prevent and treat HSV-induced symptoms, and warrants further clinical investigation.

KW - Cold sore

KW - Green tea polyphenol

KW - Herpes labialis

KW - Herpes simplex virus

KW - Herpes stomatitis

UR - http://www.scopus.com/inward/record.url?scp=84867711132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867711132&partnerID=8YFLogxK

U2 - 10.2174/187152812803251033

DO - 10.2174/187152812803251033

M3 - Article

C2 - 22583482

AN - SCOPUS:84867711132

VL - 11

SP - 364

EP - 368

JO - Current Drug Targets: Inflammation and Allergy

JF - Current Drug Targets: Inflammation and Allergy

SN - 1871-5281

IS - 5

ER -